PremiumPre-EarningsIs ANEB a Buy, Before Earnings? Anebulo Pharmaceuticals collaborates with FDA to advance selonabant Anebulo Pharmaceuticals Advances Cannabis Toxicity Solutions PremiumThe FlyAnebulo gets $1.9M cooperative grant award from NIDA for intravenous selonabant Anebulo Pharmaceuticals reports Q3 EPS (6c) vs. (11c) last year Anebulo Pharmaceuticals price target lowered to $4 from $6 at Ladenburg PremiumThe FlyAnebulo Pharmaceuticals names Richie Cunningham CEO Enphase Energy upgraded, Brighthouse downgraded: Wall Street’s top analyst calls Maxim starts Anebulo at Buy on acute cannabis intoxication opportunity